Regulation of fatty acid transport

Current Opinion in Lipidology

Volumn 15, Issue 3, 2004, Pages 309-314

  Kalant, David ^a   Cianflone, Katherine ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

acylCoA synthase; Fatty acid translocase; Fatty acid transport protein; Plasma membrane fatty acid binding protein

Indexed keywords

LONG CHAIN FATTY ACID COENZYME A LIGASE;

ENZYME ACTIVITY; EXPRESSION VECTOR; FATTY ACID TRANSPORT; GENETIC TRANSFECTION; HUMAN; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DIABETES MELLITUS; FATTY ACID TRANSPORT PROTEINS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HUMANS; MEMBRANE TRANSPORT PROTEINS; OBESITY;

MUS MUSCULUS;

EID: 2642549293     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200406000-00011     Document Type: Review

References (48)

1. Pownall HJ, Hamilton JA. Energy translocation across cell membranes and membrane models. Acta Physiol Scand 2003; 178:357-365. This review article eloquently summarizes the biophysical and cell biology evidence on protein mediated versus diffusion of fatty acids across plasma membranes. The theory, methodology and interpretation of the biophysical studies are presented in a particularly clear manner.
2. Black PN, DiRusso CC. Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification. Microbiol Mol Biol Rev 2003; 67:454-472. Similarly to the previous review, this article addresses the pros/cons of protein-mediated fatty acid transport versus diffusion. There is particular emphasis on E. coli and yeast systems and their use as (1) model fatty acid transport systems and (2) gain-of-function studies to demonstrate mammalian fatty acid transporter functionality.
3. pm and FATP, with a particular emphasis on delivery of fatty acids to muscle tissues.
4. Stahl A. A current review of fatty acid transport proteins (SLC27). Pflugers Archiv 2004; 447(5):722-727. This review presents a brief overview of the FATP family. Particularly interesting is the concept proposed of interaction and interplay between the different fatty acid transporters (such as FAT/CD36, FATP and ACS) which may coordinately mediate fatty acid transport.
5. Febbraio M, Guy E, Coburn C, et al. The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36. Mol Cell Biochem 2002; 239:193-197.
6. Bonen A, Luiken JJFP, Glatz JFC. Regulation of fatty acid transport and membrane transporters in hearth and disease. Mol Cell Biochem 2002; 239:181-192.
7. Glatz JF, Schaap FG, Binas B, et al. Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle. Acta Physiol Scand 2003; 178:367-371.
8. Besnard P, Niot I, Poirier H, et al. New insights into the fatty acid-binding protein (FABP) family in the small intestine. Mol Cell Biochem 2002; 239:139-147.
9. Hanhotf T, Lucke C, Spener F. Insights into binding of fatty acids by fatty acid binding proteins. Mol Cell Biochem 2002; 239:45-54.
10. Sigauke E, Rakheja D, Kitson K, Bennett MJ. Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review. Lab Invest 2003; 83:1543-1554.
11. Jeukendrup AE. Regulation of fat metabolism in skeletal muscle. Ann N Y Acad Sci 2002; 967:217-235.
12. Erlanson-Albertsson C. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol Scand 2003; 178:405-412.
13. Schrauwen P, Hesselink M. UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol 2002; 205 (Pt 15):2275-2285.
14. Coburn CT, Knapp FF Jr, Febbraio M, et al. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 2000; 275:32523-32529.
15. Stump DD, Zhou SL, Berk PD. Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am J Physiol Gastrointest Liver Physiol 1993; 265 (5 Pt 1):G894-G902.
16. Lewis SE, Listenberger LL, Ory DS, Schaffer JE. Membrane topology of the murine fatty acid transport protein 1. J Biol Chem 2001; 276:37042-37050.
17. Luiken JJ, Bonen A, Glatz JF. Cellular fatty acid uptake is acutely regulated by membrane-associated fatty acid-binding proteins. Prostaglandins Leukot Essent Fatty Acids 2002; 67:73-78.
18. Richards MR, Listenberger LL, Kelly AA, et al. Oligomerization of the murine fatty acid transport protein 1. J Biol Chem 2003; 278:10477-10483. This article elegantly demonstrates that FATP1 transporter functions not as a monomer, but as a dimer, using epitope tagged proteins and nonfunctional mutants. This suggests that the membrane topology of this protein may be different from other membrane transporters.
19. Bradbury MW, Berk PD. Mitochondrial aspartate aminotransferase: direction of a single protein with two distinct functions to two subcellular sites does not require alternative splicing of the mRNA. Biochem J 2000; 345 (Pt 3):423-427.
20. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994; 79:427-436.
21. Coe NR, Smith AJ, Frohnert BI, et al. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem 1999; 274:36300-36304.
22. Uchiyama A, Aoyama T, Kamijo K, et al. Molecular cloning of cDNA encoding rat very long-chain acyl-CoA synthetase. J Biol Chem 1996; 271:30360-30365.
23. Herrmann T, Buchkremer F, Gosch I, et al. Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene 2001; 270:31-40.
24. Hall AM, Smith AJ, Bernlohr DA. Characterization of the acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. J Biol Chem 2003; 278:43008-43013. This original paper provides further support of the vectorial coupling of fatty acid transport to utilization, demonstrating both fatty acid transport and ACS activity of FATP1 on discrete sites of the protein.
25. Dwyer DS. Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport. Proteins 2001; 42:531-541.
26. Williamson IM, Alvis SJ, East JM, Lee AG. The potassium channel KcsA and its interaction with the lipid bilayer. Cell Mol Life Sci 2003; 60:1581-1590.
27. Zou Z, DiRusso CC, Ctrnacta V, Black PN. Fatty acid transport in Saccharomyces cerevisiae: directed mutagenesis of FAT1 distinguishes the biochemical activities associated with Fat1p. J Biol Chem 2002; 277:31062-31071.
28. Gimeno RE, Hirsch DJ, Punreddy S, et al. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J Biol Chem 2003; 278:49512-49516. This paper provides support for the postulate that specific proteins are required in mediating fatty acid transport, and further demonstrates that in spite of the number of putative fatty acid transporters, absence of one cannot be effectively compensated by the alternate fatty acid transporters.
29. Herrmann T, van der Hoeven F, Grone HJ, et al. Mice with targeted disruption of the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene show features of lethal restrictive dermopathy. J Cell Biol 2003; 161:1105-1115. This article provides further indication of the specificity of fatty acid transporters, in this case, FATP4, disruption of which is associated with skin disorders.
30. Moulson CL, Martin DR, Lugus JJ, et al. Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development. Proc Natl Acad Sci U S A 2003; 100:5274-5279. As with the previous paper, identification of the gene responsible for a spontaneous mutation reinforces the importance and specificity of certain fatty acid transporters.
31. Gimeno RE, Ortegon AM, Patel S, et al. Characterization of a heart-specific fatty acid transport protein. J Biol Chem 2003; 278:16039-16044. Characterization of FATP6 demonstrates a predominant expression in heart muscle, suggesting a particular role there, and evidence is presented for a colocalization with FAT/CD36, again suggesting cooperation between various fatty acid transporters. This is of particular interest considering the predominance of fatty acid as an energy source in heart muscle.
32. Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci U S A 1995; 95:8625-8629.
33. Cameron-Smith D, Burke LM, Angus DJ, et al. A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle. Am J Clin Nutr 2003; 77:313-318.
34. Richert L, Lamboley C, Viollon-Abadie C, et al. Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes. Toxicol Appl Pharmacol 2003; 191:130-146. The reciprocal role of fatty acids and PPARs in influencing fatty acid transport has emerged as a regulator in recent studies. The present study is particularly relevant as it extends this concept to testing the effects of a drug targeted to PPAR activation.
35. Tanaka T, Yamamoto J, Iwasaki S, et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 2003; 100:15924-15929.
36. Zhou YT, Shimabukuro M, Koyama K, et al. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci U S A 1997; 94:6386-6390.
37. Sauer LA, Dauchy RT, Blask DE. Melatonin inhibits fatty acid transport in inguinal fat pads of hepatoma 7288CTC-bearing and normal Buffalo rats via receptor-mediated signal transduction. Life Sci 2001; 68:2835-2844.
38. Dauchy RT, Blask DE, Sauer LA, et al. Physiologiv melatonin concentration, omega-3 fatty acids, and conjugated linoleic acid inhibit fatty acid transport in rodent hind limb skeletal muscle in vivo. Comp Med 2003; 53:186-190.
39. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999; 274:19055-19062.
40. Pravenec M, Landa V, Zidek V, et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 2001; 27:156-158.
41. Nozaki S, Tanaka T, Yamashita S, et al. CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 1999; 192:129-135.
42. Gotoda T, Iizuka Y, Yamada N. Complex connection between CD36 and atherosclerosis, lipid metabolism, and insulin resistance syndromes. Curr Atheroscler Rep 2000; 2:453-454.
43. Miyaoka K, Kuwasako T, Hirano K, et al. CD36 deficiency associated with insulin resistance. Lancet 2001; 357:686-687.
44. Yanai H, Chiba H, Morimoto M, et al. Type I CD36 deficiency in humans is not associated with insulin resistance syndrome. Thromb Haemost 2000; 83:786.
45. Gertow K, Skoglund-Andersson C, Eriksson P, et al. A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution. Atherosclerosis 2003; 167:265-273. Further evidence of disease association, suggesting that FATP1 may influence postprandial lipid metabolism leading to alterations in LDL size - a recognized atherosclerotic risk factor.
46. Sukhotnik I, Gork AS, Chen M, et al. Effect of a high fat diet on lipid absorption and fatty acid transport in a rat model of short bowel syndrome. Pediatr Surg Int 2003; 19:385-390. In this surgical rat model of bowel resection, the implication of fatty acid transporter FAT/CD36 in maintenance of fat absorption is demonstrated, highlighting both the physiological role in intestine, as well as disease association.
47. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 2003; 89:3-9.
48. Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer. Biol Res 2002; 35:9-26.